CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The GNA NOW project aims to accelerate the discovery of new antibiotics targeting gram-negative bacteria, which pose significant health threats. By fostering collaboration among experts, the project seeks to advance promising compounds through early clinical development stages.
AntiMicrobial Resistance (AMR) is a global and serious threat to human health.
Gram-negative bacteria are widely regarded as the culprit representing one of the gravest dangers.
Indeed, there is a dearth of new agents able to address AMR in Gram-negative bacteria, especially compounds with novel modes of action.
Finding and developing such compounds represents a huge scientific challenge, one that requires the collaboration of stakeholders bringing many different kinds of expertise.
The world is…
STICHTING LYGATURE
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Germany, Hamburg
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
France, Lyon Cedex 03
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
BIOASTER FONDATION DE COOPERATION SCIENTIFIQUE
France, Lyon
Type: Research institute
Activity type: Research Organisations
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
